NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/10/2023
Back to search
Official data from USPTO
WUXILIAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
10/10/2023
Trademark type
Combined
Nice classes
1, 40, 42
Filing date
04/13/2021
Registration date
10/10/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/10/2023
Last transaction
10/10/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-04-00
First use in commerce
2023-04-00
Drawing code
3
Owner type
99
Owner location
DUNDALK, COUNTY LOUTH, IE
Examiner
CARROLL, DORITT
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word WuXiLiAb in stylized font with an arched line swooping from the front of the letter "u" and ending at the dot over the second letter "i" with a leaf and circle shape connected to a vertical line creating the letter "b" at the end.
Holders and representatives
Holders
WuXi Biologics Ireland Limited
Representatives
Michael T. Smith BIRCH STEWART KOLASCH & BIRCH LLP
Technical classification
Nice Classes
Class 1Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Proteins for detecting antibodies for scientific or research use; monoclonal antibodies for industrial use; monoclonal antibody reagents for scientific or research use; immunological antibodiesbeing biochemical for scientific or research use; tagged antibodies being biochemicals for scientific use; biochemicalsmonoclonal antibodies for in vitro scientific or research use; monoclonal antibodies for scientific use; monoclonal antibodies for research purposes; reagents for use in industry for development of monoclonal antibodies; tagged antibodies being biochemicals for scientific or research laboratory use; reagents for use in antibody discovery for scientific or research use
Class 40
Custom manufacture of pharmaceuticals; Custom manufacture of biopharmaceuticals; Custom manufacture of nutraceuticals; Custom manufacture of vitamins
Class 42
Scientific research; research and development services in the field of antibodies; scientific research services and new product development in the field of monoclonal antibodies; product development for others; pharmaceutical research and development services; scientific research and development; Research in the field of pharmaceuticals; research and development of new products; pharmaceutical drug development; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies
Publications
History of USPTO decisions and trademark events.
44 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/10/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/06/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/05/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/10/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/08/2023
IUAF
USE AMENDMENT FILED
07/26/2023
EISU
TEAS STATEMENT OF USE RECEIVED
07/26/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/28/2023
EX1G
SOU EXTENSION 1 GRANTED
01/26/2023
EXT1
SOU EXTENSION 1 FILED
01/26/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/26/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/02/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/07/2022
PUBO
PUBLISHED FOR OPPOSITION
06/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/18/2022
ALIE
ASSIGNED TO LIE
05/02/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/29/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/28/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/27/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/27/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/09/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/09/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/18/2021
GNRT
NON-FINAL ACTION E-MAILED
11/18/2021
CNRT
NON-FINAL ACTION WRITTEN
11/18/2021
DOCK
ASSIGNED TO EXAMINER
11/17/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/02/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/02/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/02/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/02/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/02/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/02/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/21/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/20/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/04/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/04/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/04/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/04/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/04/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/04/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/04/2021
NWAP
NEW APPLICATION ENTERED
04/16/2021
Continuous trademark protection
Get notified about every new filing that threatens WUXILIAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.